Clinical Trial Update: A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of mitoxantrone hydrochloride liposome injection in advanced pancreatic cancer is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN